Oh, H.S.; Kim, T.; Gu, D.-H.; Lee, T.S.; Kim, T.H.; Shin, S.; Shin, B.S.
Pharmacokinetics of Nafamostat, a Potent Serine Protease Inhibitor, by a Novel LC-MS/MS Analysis. Molecules 2022, 27, 1881.
https://doi.org/10.3390/molecules27061881
AMA Style
Oh HS, Kim T, Gu D-H, Lee TS, Kim TH, Shin S, Shin BS.
Pharmacokinetics of Nafamostat, a Potent Serine Protease Inhibitor, by a Novel LC-MS/MS Analysis. Molecules. 2022; 27(6):1881.
https://doi.org/10.3390/molecules27061881
Chicago/Turabian Style
Oh, Hyeon Seok, Taehyung Kim, Dong-Hyeon Gu, Tae Suk Lee, Tae Hwan Kim, Soyoung Shin, and Beom Soo Shin.
2022. "Pharmacokinetics of Nafamostat, a Potent Serine Protease Inhibitor, by a Novel LC-MS/MS Analysis" Molecules 27, no. 6: 1881.
https://doi.org/10.3390/molecules27061881
APA Style
Oh, H. S., Kim, T., Gu, D.-H., Lee, T. S., Kim, T. H., Shin, S., & Shin, B. S.
(2022). Pharmacokinetics of Nafamostat, a Potent Serine Protease Inhibitor, by a Novel LC-MS/MS Analysis. Molecules, 27(6), 1881.
https://doi.org/10.3390/molecules27061881